Action and Spectrum:
tocilizumab is a monoclonal antibody medication that targets interleukin-6 (IL-6) receptor. It is used to treat a range of inflammatory conditions, including rheumatoid arthritis, giant cell arteritis, systemic juvenile idiopathic arthritis, and cytokine release syndrome (CRS) associated with cancer treatments. Tocilizumab works by blocking the action of IL-6, a protein that plays a role in inflammation and the immune response. By blocking the IL-6 receptor, tocilizumab reduces inflammation and helps to control symptoms in individuals with the conditions mentioned above.
